2-FMA

2-FMA is controlled in Belgium under the Royal Decree of 6 September 2017 as an amphetamine derivative in Annex IVa. The annex’s generic 1-phenylpropan-2-amine structure permits an N-methyl substituent and a halogen at any position on the phenyl ring, which encompasses 2-FMA. Since the Decree entered into force on its publication on 26 September 2017, importing, exporting, transporting, manufacturing, possessing, selling, supplying, or acquiring the substance requires prior authorisation; unauthorised breaches are punishable under the 1921 Drugs Act.

2-FMA is controlled under Schedule I, item 18, of the Controlled Drugs and Substances Act as an analogue of methamphetamine. The Act defines an analogue by substantial structural similarity; PubChem identifies 2-FMA as 1-(2-fluorophenyl)-N-methylpropan-2-amine and methamphetamine as N-methyl-1-phenylpropan-2-amine, structures that differ by fluorine substitution on the phenyl ring. Under the Act, unauthorized possession, trafficking, and production are prohibited.

2-FMA is controlled as an isomer of 4-FMA under Article 1 of Chile’s Decree No. 867, as amended by Decree No. 416, published on 2 September 2017. The regulation classifies 4-FMA as a dependence-producing psychotropic substance and extends that list to its isomers unless expressly excepted. Under Law No. 20.000, unauthorized import, export, transport, acquisition, transfer, possession, supply, storage, or carrying of listed substances constitutes trafficking and is subject to the penalties in Article 1.

Designated a controlled substance in October 2015. Production, sale, and possession are prohibited under national drug control regulations.

Finland lists 2-fluoromethamphetamine (2-FMA) in Annex IV to the Government Decree on substances, preparations and plants considered narcotics. As a narcotic, its production, manufacture, import, export, transport, distribution, trade, handling, possession and use are prohibited, subject to statutory medical, research, supervisory and industrial exceptions.

Listed under Anlage I of the Betäubungsmittelgesetz (Narcotics Act, Schedule I) since December 13, 2014.²⁶ Manufacturing, possession, import, export, purchase, sale, procurement, and dispensing without a license are illegal.²⁶ Violations are punishable by fines or imprisonment up to five years.²⁷

2-FMA (N-methyl-1-(2-fluorophenyl)propan-2-amine) is a controlled drug under paragraph 1A of the Schedule to the Misuse of Drugs Act 1977: it is an N-alkyl-α-methylphenethylamine with a halo substitution in the phenyl ring. The Act prohibits possession of a controlled drug, and the Misuse of Drugs Regulations 2017 prohibit its production, supply, importation and exportation except as authorised by the regulations or a licence.

2-FMA falls within Lijst IA of the Opiumwet as a substance derived from 2-fenethylamine: the structural definition permits a fluorine substituent on the phenyl ring and an alkyl substituent on the nitrogen. The Opiumwet prohibits importing or exporting, preparing, processing, selling, supplying, transporting, possessing, and manufacturing a substance in a Lijst IA substance group or a preparation containing it. The Lijst IA regime entered into force on 1 July 2025.

2-FMA is covered as a Class C controlled-drug analogue under Schedule 3 Part 7 of the Misuse of Drugs Act 1975. Section 2(1) defines a controlled drug analogue as a substance, including substances specified or described in Part 7 of Schedule 3, having a structure substantially similar to that of a controlled drug, subject to exclusions for substances in Schedules 1 or 2 or Parts 1 to 6 of Schedule 3, pharmacy-only/prescription/restricted medicines, approved Psychoactive Substances Act products, and non-psychoactive THC analogues. PubChem's exact identity is 2-fluoromethamphetamine (not 2-fluoroamphetamine/2-FA): 1-(2-fluorophenyl)-N-methylpropan-2-amine. The N-methyl, alpha-methyl, and ortho-fluoro substitutions fit the Part 7 amphetamine-analogue text. Section 6 prohibits unlicensed import/export, production/manufacture, Class C supply to a person under 18, Class C sale to a person 18 or over, and possession for those dealing purposes; the Class C maximum under section 6(2)(c) is 8 years' imprisonment (and conspiracy under section 6(2A)(c) carries up to 7 years). Section 7 prohibits procurement, possession, use, and Class C supply/dealing; the ordinary Class C possession/use maximum is 3 months' imprisonment and/or NZ$500, with a statutory proviso against custodial sentencing for a Class C-only offence absent previous convictions or exceptional circumstances. New Zealand Police's official summary states the Class C maxima and gives up to 1 year imprisonment and/or NZ$1,000 for summary Class C supply or manufacture. Section 29C provides a limited analogue-possession defence only where the defendant proves a purpose other than consumption/use or supply, or supply/administration under a Director-General of Health-approved procedure. These are statutory maximums, not predictions of sentence. The classification as an analogue applies only to laboratory-confirmed 2-FMA and does not extend to an unknown mixture, different isomer, medicine, or approved product.

Norway’s Narkotikaforskriften lists 2-FMA (2-fluoromethamphetamine) as prohibited under section 5. Its manufacture, acquisition, sale, import, export, storage, possession, and use are prohibited unless the Ministry grants an exception for medical or scientific needs.

2-FMA is controlled in Poland as a new psychoactive substance through the generic Group I-NPS entry for derivatives of 2-phenylethylamine. The generic definition covers compounds with a fluorine-substituted ring and an N-alkyl substituent, which encompasses 2-fluoromethamphetamine. Manufacture, import, export, intra-EU acquisition or supply, and placing a new psychoactive substance on the market require authorization; unauthorized possession is punishable by a fine.

Singapore’s Misuse of Drugs Act 1973 classifies 2-FMA as a Class A controlled drug because its First Schedule entry for N-Methyl-1-(4-fluorophenyl)propan-2-amine includes fluoro positional isomers in the phenyl ring. The Act prohibits the unauthorised possession, trafficking, import, export and manufacture of controlled drugs.

Specifically named under Verzeichnis E of Swiss controlled substances regulations. Unauthorized possession and distribution are prohibited.

As of 28 August 2026, 2-FMA is prohibited under Turkish law. The Emniyet Genel Müdürlüğü/TUBİM Türkiye Uyuşturucu Raporu 2014 identifies Decision 2013/5742 (16 December 2013; published 25 January 2014 in Official Gazette No. 28893) in its Annex 2, and item 48 expressly reads '2-FMA ismi ile bilinen (RS)-1-(2-fluorophenyl)-N-methylpropan-2-amine.' The 2015 Official Gazette decision contains the generic AMFETAMİN (FENİLETİLAMİN) TÜREVLERİ schedule, covering alkyl substitutions on the phenethylamine side chain and amine and halogen substitution on the phenyl ring, independently reinforcing control of this alpha-methyl, N-methyl, ortho-fluoro compound. The Narkotik Suçlarla Mücadele Başkanlığı mandate provides that the EWS brings necessary NPS under Law No. 2313 and that generic classification brings many synthetic derivatives under the law. The 2025 Türkiye Uyuşturucu Raporu states that generic classification began in 2015 and that 1,078 substances were included under Law No. 2313 during 2008–2024, including 453 directly controlled through generic classification and 143 phenethylamines; the framework remains in active use. Decision 11418, dated 13 June 2026, is the newest 2313 inclusion decision as of 28 August 2026. TCK Article 188(1) sets 20–30 years plus a judicial fine for unauthorized manufacture/import/export; Article 188(3) sets at least 10 years plus a judicial fine for unauthorized domestic sale, offer, giving, dispatch, transport, storage, purchase, acceptance or possession, or at least 15 years where the recipient is a child; Article 188(4)(a) expressly names amphetamine and derivatives; and Article 191(1) sets 2–5 years for purchase, acceptance or possession for use or use, with five-year postponement and probation provisions in Article 191(2)–(3). 2-FMA is also known as 2-Fluoromethamphetamine, with the IUPAC name 1-(2-fluorophenyl)-N-methylpropan-2-amine, formula C10H14FN and SMILES CC(CC1=CC=CC=C1F)NC. No licensed therapeutic product or prescription exception for 2-FMA is established.

2-FMA (2-fluoromethamphetamine) is listed in Table I, List No. 2 of Ukraine’s List of narcotic drugs, psychotropic substances and precursors. List No. 2 covers especially dangerous psychotropic substances whose circulation is prohibited. The substance was added by Cabinet of Ministers Resolution No. 600, effective 23 July 2019, and remains in the current consolidated List.

Controlled under the amphetamine analogue clause of the Misuse of Drugs Act 1971.⁵⁷ Class A substances carry the most severe penalties, including up to seven years imprisonment for possession and life imprisonment for supply.⁵⁸

The current federal schedules name methamphetamine in Schedule II but do not separately name 2-FMA (2-fluoromethamphetamine). Under the regulatory definition, “isomer” in the methamphetamine entry means an optical isomer; PubChem links the names 2-Fluoromethamphetamine and 2-FMA to CID 24257263 and identifies it as the distinct fluorinated compound 1-(2-fluorophenyl)-N-methylpropan-2-amine. Federal law separately defines a “controlled substance analogue” in 21 U.S.C. § 802(32). A substance meeting that definition is treated as a Schedule I controlled substance to the extent it is intended for human consumption.⁶⁶

2-FMA's unscheduled status does not establish that it is generally lawful. The French narcotics schedule's Article 1 limits classification to substances and preparations in its annexes. In Annex III, the ANSM regulator copy expressly names 4-fluoroamphétamine (4-FA), amphétamine, and méthamphétamine and son racémate, but does not name 2-FMA, 2-fluorométhamphétamine, 2-fluoro-N-methylamphetamine or 1-(2-fluorophenyl)-N-methylpropan-2-amine. Annex IV's generic phenethylamine/alpha-methylphenethylamine clause requires a substituted phenyl ring and an amine substituted by at least one benzyl group with the specified benzyl-ring substituent; 2-FMA has an N-methyl group, not an N-benzyl group, so this clause does not cover 2-FMA. The separate ANSM psychotropic schedule states that only products listed in its annex are psychotropes and its exhaustive parts do not name 2-FMA or its IUPAC identity. ANSM's February 2023 operator guide confirms that the French narcotics and psychotropic lists are fixed by the modified 22 February 1990 arrêté and that activities involving listed substances are prohibited unless authorized. Service-Public guidance states that illicit use of a classified stupéfiant carries up to one year imprisonment and EUR 3,750 fine, with a fixed criminal fine of EUR 500 (EUR 400 reduced; EUR 1,000 increased), and specified public-authority/public-service/transport roles can raise the maximum to five years and EUR 75,000. Its current customs guidance states that illicit detention, transport or entry into France of a stupéfiant is illegal and carries up to ten years and EUR 7,500,000; these penalties are conditional on the substance being classified and therefore do not themselves establish penalties for an unscheduled 2-FMA.